Dr. Tawfik is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
VA Outpatient Clinic
6211 Waterford Blvd
Evansville, IN 47715Phone+1 812-465-6205
Education & Training
- University of AlbertaPh.D., Pharmacology, 1987
- University of AlbertaPhD, Pharmacology, Alberta Heritage Foundation for Medical Research, 1983 - 1986
- Baghdad University Medical CollegeM.S., Clinical Pharmacology, 1979
- University of Baghdad College of MedicineClass of 1977
Certifications & Licensure
- IN State Medical License 1996 - 2025
- KY State Medical License 2002 - 2025
- NC State Medical License 2013 - 2020
- MA State Medical License 1999 - 2000
- MI State Medical License 1996 - 2000
- VA State Medical License 1998 - 2000
- NY State Medical License 1998 - 1999
- Royal College of Physicians & Surgeons of CanadaFRCPC, Certificate of Specialty in Dermatology
Awards, Honors, & Recognition
- Fellow (ASLMS) American Society of Laser Medicine & Surgery
- Readers� Choice Award for Best Dermatologist Evansville Courier &Press, 2012-2014
- CMS Meaningful Use Stage 1 Certification eClinicalWorks EHR, eClinicalWorks LLC, 2011-2013
- Join now to see all
Publications & Presentations
PubMed
- 195 citationsImiquimod 5% cream for the treatment of actinic keratosis: results from two phase III, randomized, double-blind, parallel group, vehicle-controlled trialsMark Lebwohl, Scott M. Dinehart, David A. Whiting, Peter K. Lee, Naji H. Tawfik
Journal of the American Academy of Dermatology. 2004-05-01 - 405 citationsA novel targeted T-cell modulator, efalizumab, for plaque psoriasisMark Lebwohl, Stephen K. Tyring, Tiffani K. Hamilton, Darryl Toth, Scott Glazer
The New England Journal of Medicine. 2003-11-20 - 84 citationsOral terbinafine in the treatment of toenail onychomycosis: North American multicenter trialLynn A. Drake, Neil H. Shear, Jon P. Arlette, Richard Cloutier, Frederick W. Danbye
Journal of the American Academy of Dermatology. 1997-11-01
Journal Articles
- Efficacy and safety observed during 24 weeks of efalizumab therapy in patients with moderate to severe plaque psoriasisAlan Menter, et al, for the Efalizumab Study Group (Tawfik, N.), Archives of Dermatology, 1/1/2005
- Imiquimod 5% cream for the treatment of actinic keratosis: Results from two phase III, randomized, double-blind, parallel group, vehicle-controlled trialsLebwohl, M., Tawfik N.H., et al, J Am Acad Dermatology, 1/1/2004
- Imiquimod 5% cream for the treatment of superficial basal cell carcinoma: Results from two phase III, randomized, vehicle-controlled studiesGeisse, J., et al (Tawfik, N.), J Am Acad Dermatology, 1/1/2004
- Join now to see all
Abstracts/Posters
- The effect of dietary fatty acids on calcium uptake in rat heart�s sarcoplasmic reticulum.Dryden, W., and Tawfik, N., Proc 30th Congress Intr Union Physiol Sci, 1/1/1986
- Site of action of dietary fatty acids in regulating cardiac function.Tawfik, N., and Dryden, W., J Mol Cell Cardiol, 1/1/1985
Lectures
- Oral Terbinafine in the treatment of toenail onychomycosis: ANorth American Multicenter Clinical Trial.New Orleans, LA - 1/1/1995
- Practical clinical recommendations for antibiotics in dermatology.Vancouver, British Columbia, Canada - 1/1/1993
- Naproxen induced pseudoporphyria.Whitehorse, Yukon, Canada - 1/29/1990
- Join now to see all
Professional Memberships
- Fellow
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: